Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malawi | 33 | 2024 | 302 | 2.290 |
Why?
|
Hospitals, Rural | 1 | 2023 | 176 | 0.740 |
Why?
|
Personnel Selection | 2 | 2019 | 196 | 0.720 |
Why?
|
HIV Infections | 13 | 2022 | 17342 | 0.690 |
Why?
|
Rural Health Services | 2 | 2018 | 384 | 0.560 |
Why?
|
Health Services Administration | 1 | 2017 | 63 | 0.560 |
Why?
|
Malnutrition | 2 | 2021 | 622 | 0.510 |
Why?
|
Rural Population | 12 | 2024 | 2277 | 0.480 |
Why?
|
Health Services Research | 2 | 2019 | 1808 | 0.440 |
Why?
|
Hypertension | 7 | 2024 | 8532 | 0.420 |
Why?
|
Communicable Diseases | 2 | 2018 | 871 | 0.420 |
Why?
|
Public Health | 2 | 2021 | 2671 | 0.360 |
Why?
|
Interviews as Topic | 1 | 2017 | 2697 | 0.340 |
Why?
|
Tuberculosis | 2 | 2021 | 2015 | 0.320 |
Why?
|
Hospitals, District | 3 | 2024 | 114 | 0.320 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2024 | 940 | 0.290 |
Why?
|
Clinical Competence | 3 | 2019 | 4790 | 0.280 |
Why?
|
Disease Management | 1 | 2017 | 2506 | 0.270 |
Why?
|
Biopsy | 1 | 2018 | 6763 | 0.270 |
Why?
|
Cost-Benefit Analysis | 4 | 2024 | 5493 | 0.260 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2014 | 1894 | 0.250 |
Why?
|
Patient Compliance | 2 | 2021 | 2688 | 0.250 |
Why?
|
Health Policy | 4 | 2019 | 2682 | 0.240 |
Why?
|
Sarcoma, Kaposi | 2 | 2018 | 374 | 0.220 |
Why?
|
Asthma | 1 | 2022 | 6234 | 0.220 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3415 | 0.210 |
Why?
|
Program Evaluation | 4 | 2021 | 2486 | 0.210 |
Why?
|
Primary Health Care | 2 | 2018 | 4677 | 0.210 |
Why?
|
Africa South of the Sahara | 3 | 2023 | 745 | 0.200 |
Why?
|
Drugs, Essential | 1 | 2022 | 71 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 3 | 2020 | 3196 | 0.180 |
Why?
|
Liberia | 1 | 2021 | 174 | 0.180 |
Why?
|
Patents as Topic | 1 | 2021 | 111 | 0.180 |
Why?
|
Policy Making | 3 | 2019 | 541 | 0.180 |
Why?
|
Humans | 48 | 2024 | 760740 | 0.170 |
Why?
|
Depression | 2 | 2021 | 8132 | 0.160 |
Why?
|
Capacity Building | 2 | 2019 | 259 | 0.160 |
Why?
|
World Health Organization | 2 | 2023 | 1321 | 0.160 |
Why?
|
Health Facilities | 2 | 2024 | 578 | 0.160 |
Why?
|
Moral Obligations | 1 | 2019 | 93 | 0.160 |
Why?
|
Perinatal Care | 1 | 2020 | 244 | 0.140 |
Why?
|
Internship and Residency | 1 | 2017 | 5878 | 0.140 |
Why?
|
Community Health Services | 1 | 2021 | 654 | 0.130 |
Why?
|
Proteinuria | 1 | 2019 | 605 | 0.130 |
Why?
|
Health Literacy | 1 | 2021 | 443 | 0.130 |
Why?
|
Inservice Training | 1 | 2018 | 375 | 0.130 |
Why?
|
Minority Health | 1 | 2016 | 79 | 0.130 |
Why?
|
Social Identification | 1 | 2016 | 108 | 0.130 |
Why?
|
Family Characteristics | 1 | 2021 | 992 | 0.130 |
Why?
|
Stavudine | 1 | 2015 | 85 | 0.130 |
Why?
|
Fees and Charges | 1 | 2016 | 192 | 0.120 |
Why?
|
Depressive Disorder, Major | 2 | 2024 | 4764 | 0.120 |
Why?
|
Pregnant Women | 1 | 2020 | 567 | 0.120 |
Why?
|
Mass Screening | 3 | 2020 | 5425 | 0.120 |
Why?
|
Research Personnel | 1 | 2019 | 588 | 0.120 |
Why?
|
Critical Care | 3 | 2023 | 2691 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 3680 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1351 | 0.120 |
Why?
|
Nevirapine | 1 | 2015 | 273 | 0.110 |
Why?
|
Chronic Disease | 3 | 2023 | 9310 | 0.110 |
Why?
|
Adult | 17 | 2024 | 220995 | 0.110 |
Why?
|
Lamivudine | 1 | 2015 | 366 | 0.110 |
Why?
|
Critical Illness | 2 | 2023 | 2709 | 0.110 |
Why?
|
Human Rights | 1 | 2016 | 309 | 0.110 |
Why?
|
Intensive Care Units | 2 | 2023 | 3743 | 0.110 |
Why?
|
Poverty | 3 | 2023 | 2692 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1139 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12143 | 0.110 |
Why?
|
Health Plan Implementation | 1 | 2015 | 335 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2896 | 0.100 |
Why?
|
Pregnancy | 5 | 2021 | 29869 | 0.100 |
Why?
|
Employment | 1 | 2018 | 1113 | 0.100 |
Why?
|
Rwanda | 1 | 2014 | 656 | 0.100 |
Why?
|
Retrospective Studies | 5 | 2023 | 80583 | 0.100 |
Why?
|
Home Care Services | 1 | 2018 | 648 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2545 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1937 | 0.090 |
Why?
|
Female | 18 | 2024 | 392203 | 0.090 |
Why?
|
Educational Measurement | 1 | 2017 | 1252 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2292 | 0.090 |
Why?
|
Neoplasms | 2 | 2018 | 22131 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5838 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2149 | 0.080 |
Why?
|
Minority Groups | 1 | 2016 | 1202 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10203 | 0.080 |
Why?
|
Africa | 2 | 2023 | 714 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2020 | 0.080 |
Why?
|
Tanzania | 2 | 2024 | 1390 | 0.070 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5430 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4309 | 0.070 |
Why?
|
Prevalence | 4 | 2019 | 15702 | 0.070 |
Why?
|
Male | 13 | 2024 | 360402 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1400 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2018 | 4010 | 0.070 |
Why?
|
Ambulatory Care Facilities | 2 | 2024 | 934 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1419 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26065 | 0.060 |
Why?
|
Hospitals | 3 | 2023 | 3879 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2252 | 0.060 |
Why?
|
Middle Aged | 11 | 2024 | 220603 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10072 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7390 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2492 | 0.060 |
Why?
|
Beclomethasone | 1 | 2024 | 38 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3739 | 0.060 |
Why?
|
Young Adult | 4 | 2018 | 59191 | 0.050 |
Why?
|
Blood Glucose | 3 | 2024 | 6390 | 0.050 |
Why?
|
Censuses | 1 | 2024 | 198 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3727 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 88247 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5334 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3325 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2024 | 5239 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8652 | 0.040 |
Why?
|
Senegal | 1 | 2020 | 255 | 0.040 |
Why?
|
Nepal | 1 | 2020 | 304 | 0.040 |
Why?
|
Palliative Care | 1 | 2014 | 3593 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20077 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2020 | 201 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5811 | 0.040 |
Why?
|
Ethiopia | 1 | 2020 | 460 | 0.040 |
Why?
|
Haiti | 1 | 2020 | 550 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 467 | 0.040 |
Why?
|
Bangladesh | 1 | 2020 | 732 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2024 | 1663 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4524 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54364 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 176 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 196 | 0.040 |
Why?
|
Live Birth | 1 | 2021 | 510 | 0.040 |
Why?
|
Developing Countries | 2 | 2021 | 2868 | 0.040 |
Why?
|
Social Control Policies | 1 | 2017 | 9 | 0.040 |
Why?
|
Politics | 1 | 2024 | 813 | 0.040 |
Why?
|
India | 1 | 2024 | 2286 | 0.040 |
Why?
|
Myanmar | 1 | 2016 | 43 | 0.040 |
Why?
|
Mentors | 1 | 2021 | 661 | 0.030 |
Why?
|
Research Design | 2 | 2024 | 6174 | 0.030 |
Why?
|
Kenya | 1 | 2018 | 757 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2024 | 1061 | 0.030 |
Why?
|
Family Planning Services | 1 | 2018 | 266 | 0.030 |
Why?
|
Risk Factors | 5 | 2021 | 74128 | 0.030 |
Why?
|
Maternal Health Services | 1 | 2020 | 460 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1895 | 0.030 |
Why?
|
Aged | 4 | 2019 | 169092 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58919 | 0.030 |
Why?
|
Child | 1 | 2021 | 80089 | 0.030 |
Why?
|
Breast Feeding | 1 | 2021 | 1355 | 0.030 |
Why?
|
Comorbidity | 2 | 2019 | 10507 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2024 | 2768 | 0.030 |
Why?
|
Health Priorities | 1 | 2015 | 375 | 0.030 |
Why?
|
Geography | 1 | 2014 | 652 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1927 | 0.030 |
Why?
|
Quality of Life | 2 | 2024 | 13359 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2703 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20988 | 0.020 |
Why?
|
Health Resources | 1 | 2017 | 934 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 41464 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2174 | 0.020 |
Why?
|
Prenatal Care | 1 | 2018 | 1140 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26183 | 0.020 |
Why?
|
Health Expenditures | 1 | 2021 | 2363 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3599 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2015 | 1086 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2597 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3196 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5074 | 0.020 |
Why?
|
Pain Measurement | 1 | 2014 | 3546 | 0.010 |
Why?
|
Qualitative Research | 1 | 2014 | 3017 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8473 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18381 | 0.010 |
Why?
|
Caregivers | 1 | 2014 | 2241 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15250 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14599 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23974 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39908 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 64572 | 0.010 |
Why?
|
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_